Osteotomy – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 12 Jun 2026 10:31:42 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Osteotomy – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on Ropivacaine Hydrochloride for Reducing Pain After Hip Surgery in Patients Undergoing Periacetabular Osteotomy https://clinicaltrials.eu/trial/study-on-ropivacaine-hydrochloride-for-reducing-pain-after-hip-surgery-in-patients-undergoing-periacetabular-osteotomy/ Wed, 29 Apr 2026 14:28:03 +0000 https://clinicaltrials.eu/trial/study-on-ropivacaine-hydrochloride-for-reducing-pain-after-hip-surgery-in-patients-undergoing-periacetabular-osteotomy/ This clinical trial is focused on studying the effects of a specific type of pain relief method called the pericapsular nerve group (PENG) block for patients undergoing a surgical procedure known as periacetabular osteotomy. This surgery is typically performed to correct hip problems. The study aims to determine if the PENG block is more effective than a placebo in reducing pain and other complications immediately after the surgery.

During the trial, participants will receive either the PENG block using a medication called Ropivacaine or a placebo, which in this case is Saline. Ropivacaine is a medication used to numb a specific area of the body to help manage pain. The PENG block involves injecting the medication near the nerves around the hip to provide pain relief after the surgery.

The study will monitor participants for 24 hours after their surgery to assess their pain levels and any other complications. This will help researchers understand how effective the PENG block is in managing pain compared to the placebo. The goal is to improve pain management techniques for patients undergoing hip surgery, potentially leading to better recovery experiences.

]]>